Brand Intelligence Graph
Company Overview
About Breathe Well-being
Breathe Well-being is a Gurugram, India-based digital therapeutics platform — backed by Y Combinator (W20) with $12.9 million in total funding including a ₹50 crore ($6 million) pre-Series B in 2023 and a $5.5 million Series A in August 2021 led by Accel with General Catalyst, 3one4 Capital, and Scott Shleifer — providing Indians with clinically validated digital programs for reversing and managing Type 2 diabetes, PCOD (polycystic ovarian disease), thyroid disorders, and hypertension through structured weight loss programs combining personalized nutrition coaching, behavioral change support, and continuous glucose monitoring. Founded in 2020 with a mission to help 1 million Indians reverse Type 2 diabetes by 2025, Breathe targets India's 150 million chronic lifestyle disease patients.
Business Model & Competitive Advantage
Breathe Well-being's digital therapeutics model applies the scientific evidence for intensive lifestyle intervention to India's chronic disease crisis at digital scale: the Diabetes Prevention Program (the landmark US clinical trial) demonstrated that intensive lifestyle modification (structured dietary change, exercise, and behavioral support) reduces Type 2 diabetes onset by 58% and enables clinical remission in established T2D patients — but delivering this intervention through in-person clinical programs costs ₹50,000-₹150,000 per patient per year, limiting access to wealthy urban Indians. Breathe's app-based delivery (nutritionist-supervised personalized meal planning, daily behavioral coaching, AI-powered food logging with Indian food database, metabolic health tracking) reduces the cost to ₹10,000-₹30,000 per year while maintaining clinical effectiveness. The Indian food database specificity (Indian regional cuisines, seasonal ingredients, home cooking methods, restaurant options in Indian cities) addresses the localization gap in global digital health apps that recommend Western dietary patterns irrelevant to Indian eating habits.
Competitive Landscape 2025–2026
In 2025, Breathe Well-being competes in the India digital therapeutics, chronic disease management, and diabetes reversal market with Twin Health (AI-powered diabetes reversal, $155M raised), Practo (India healthcare platform, $180M raised), and Fitterfly (India metabolic health platform, $33M raised) for the 150 million Indian patients with chronic lifestyle diseases seeking digital weight management and metabolic health programs. Accel India and General Catalyst's co-investment reflects conviction in India's digital health adoption tailwind — smartphone penetration, affordable mobile data, and chronic disease burden create strong market conditions for digital therapeutic adoption. The pre-Series B ₹50 crore round in 2023 reflects the continued investor conviction in Breathe's clinical outcome data and market expansion. The 2025 strategy focuses on B2B employer health benefit deployments (Indian corporates covering Breathe subscriptions for employees with metabolic disease risk), expanding the PCOD and thyroid-specific program modules, and growing the tier 2 and tier 3 Indian city patient acquisition.
Recent Activity
View all →Key Differentiators
Strong Challenger
Breathe Well-being is an established challenger with significant market presence and competitive offerings in Healthcare.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Epic Systems
Epic Systems Corporation was founded in 1979 by Judith Faulkner and is headquartered in Verona, Wisconsin, remaining privately held with Faulkner as majority owner. The company develops large-scale el
athenahealth
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on
Pfizer
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The compan
Moderna
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stép
Amgen
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologic
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
Compare Breathe Well-being with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Breathe Well-being? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Breathe Well-being Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Breathe Well-being vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →